SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor

Conditions:   Autonomous Cortisol Secretion (ACS);   ACTH-Independent Cushing Syndrome;   ACTH-Independent Adrenal Cushing Syndrome, Somatic Interventions:   Drug: SPI-62 dose1;   Drug: SPI-62 dose 2;   Drug: SPI-62 dose 3;   Drug: SPI-62 dose 4;   Drug: Placebo Sponsor:   Sparrow Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials